Amelie Lupp
Impact in
-
- Neuroscience and Neuropharmacology Research
- Hepatology top 5%
Papers in
- Pharmacology 26
- Pharmacogenetics and Drug Metabolism 21
- Oncology 36
- Drug Transport and Resistance Mechanisms 16
- Lung Cancer Research Studies 11
- Co-authors
- Stefan Schulz (45 shared papers)Daniel Kaemmerer (30 shared papers)Jörg Sänger (26 shared papers)Georg Hertting (2 shared papers)David J. Dooley (2 shared papers)Thomas J. Feuerstein (6 shared papers)Ralph Markus Wirtz (8 shared papers)Merten Hommann (6 shared papers)
- Journals
- Experimental and Toxicologic Pathology (21 papers)International Journal of Molecular Sciences (8 papers)Scientific Reports (7 papers)Oncotarget (5 papers)PLoS ONE (5 papers)
- Partner nations
- GermanyFranceUnited Kingdom
In The Last Decade
Amelie Lupp
149 papers receiving 5.3k citations
Amelie Lupp's Hit Papers
Peers
Comparison fields: 5 of 136
- Cellular and Molecular Neuroscience 852
- Hepatology 309
- Endocrinology, Diabetes and Metabolism 507
- Oncology 803
- Epidemiology 984
Countries citing papers authored by Amelie Lupp
This map shows the geographic impact of Amelie Lupp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amelie Lupp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amelie Lupp more than expected).
Fields of papers citing papers by Amelie Lupp
This network shows the impact of papers produced by Amelie Lupp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amelie Lupp. The network helps show where Amelie Lupp may publish in the future.
Co-authors
The 25 scholars most cited alongside Amelie Lupp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 152 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors Hit paper breakdown → | 2021 | 451 |
| 2 | The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors Hit paper breakdown → | 2023 | 307 |
| 3 | 2017 | 251 | |
| 4 | 2015 | 219 | |
| 5 | 2018 | 198 | |
| 6 | 2016 | 159 | |
| 7 | 2012 | 157 | |
| 8 | 2020 | 151 | |
| 9 | 2015 | 147 | |
| 10 | 1987 | 139 | |
| 11 | 2011 | 124 | |
| 12 | Comparing of IRS and Her2 as immunohistochemical scoring schemes in gastroenteropancreatic neuroendocrine tumors. | 2012 | 121 |
| 13 | 2012 | 119 | |
| 14 | 2017 | 90 | |
| 15 | 2015 | 85 | |
| 16 | 2010 | 83 | |
| 17 | 2005 | 80 | |
| 18 | 1992 | 77 | |
| 19 | 2007 | 76 | |
| 20 | 2012 | 72 |
About Amelie Lupp
Amelie Lupp is a scholar working on Pharmacology, Oncology, Hepatology, Epidemiology and Cellular and Molecular Neuroscience, having authored 152 papers that have together received 5.4k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (28 papers), Pharmacogenetics and Drug Metabolism (21 papers), Organ Transplantation Techniques and Outcomes (17 papers), Drug Transport and Resistance Mechanisms (16 papers), Neuroscience and Neuropharmacology Research (13 papers), Liver physiology and pathology (12 papers), Lung Cancer Research Studies (11 papers) and Receptor Mechanisms and Signaling (9 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (852 citations), Hepatology (309 citations), Endocrinology, Diabetes and Metabolism (507 citations), Oncology (803 citations) and Epidemiology (984 citations). Amelie Lupp has collaborated with scholars based in Germany, France and United Kingdom. Frequent co-authors include Stefan Schulz, Daniel Kaemmerer, Jörg Sänger, Georg Hertting, David J. Dooley, Thomas J. Feuerstein, Ralph Markus Wirtz, Merten Hommann, G. Hertting and Richard Paul Baum. Their work appears in journals such as Experimental and Toxicologic Pathology, International Journal of Molecular Sciences, Scientific Reports, Oncotarget and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.